title: Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey.
abstract: BACKGROUND
  Results of several epidemiologic and clinical studies have suggested that there is an excess risk of hypertension and diabetes mellitus in persons with suboptimal intake of vitamin D.
  
  
  METHODS
  We examined the association between serum levels of 25-hydroxyvitamin D (25[OH]D) and select cardiovascular disease risk factors in US adults. A secondary analysis was performed with data from the Third National Health and Nutrition Examination Survey, a national probability survey conducted by the National Center for Health Statistics between January 1, 1988, and December 31, 1994, with oversampling of persons 60 years and older, non-Hispanic black individuals, and Mexican American individuals.
  
  
  RESULTS
  There were 7186 male and 7902 female adults 20 years and older with available data in the Third National Health and Nutrition Examination Survey. The mean 25(OH)D level in the overall sample was 30 ng/mL (75 nmol/L). The 25(OH)D levels were lower in women, elderly persons (>or=60 years), racial/ethnic minorities, and participants with obesity, hypertension, and diabetes mellitus. The adjusted prevalence of hypertension (odds ratio [OR], 1.30), diabetes mellitus (OR, 1.98), obesity (OR, 2.29), and high serum triglyceride levels (OR, 1.47) was significantly higher in the first than in the fourth quartile of serum 25(OH)D levels (P<.001 for all).
  
  
  CONCLUSIONS
  Serum 25(OH)D levels are associated with important cardiovascular disease risk factors in US adults. Prospective studies to assess a direct benefit of cholecalciferol (vitamin D) supplementation on cardiovascular disease risk factors are warranted.
authors.affiliation: Department of Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, Calif., 90262, USA.
authors.forename: David
authors.initials: D
authors.lastname: Martins
authors.forename: Myles
authors.initials: M
authors.lastname: Wolf
authors.forename: Deyu
authors.initials: D
authors.lastname: Pan
authors.forename: Ashraf
authors.initials: A
authors.lastname: Zadshir
authors.forename: Naureen
authors.initials: N
authors.lastname: Tareen
authors.forename: Ravi
authors.initials: R
authors.lastname: Thadhani
authors.forename: Arnold
authors.initials: A
authors.lastname: Felsenfeld
authors.forename: Barton
authors.initials: B
authors.lastname: Levine
authors.forename: Rajnish
authors.initials: R
authors.lastname: Mehrotra
authors.forename: Keith
authors.initials: K
authors.lastname: Norris
mesh_terms: D000328:Adult; D000367:Age Factors; D002318:Cardiovascular Diseases / Q000097:blood*; D003920:Diabetes Mellitus / Q000097:blood / Q000453:epidemiology; D005260:Female; D006306:Health Surveys; D006801:Humans; D006973:Hypertension / Q000097:blood / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000097:blood / Q000453:epidemiology; D015995:Prevalence; D044469:Racial Groups; D012307:Risk Factors; D012709:Serum Albumin / Q000032:analysis; D012737:Sex Factors; D014280:Triglycerides / Q000097:blood; D014481:United States / Q000453:epidemiology; D014807:Vitamin D / Q000031:analogs & derivatives* / Q000097:blood
chemical_list: D012709:Serum Albumin; D014280:Triglycerides; D014807:Vitamin D; C104450:25-hydroxyvitamin D